期刊文献+

高效液相色谱法测定术前儿童口服复方氯胺酮的血药浓度 被引量:4

Determination of blood concentration of compound ketamine oral solution in preoperative children by HPLC
在线阅读 下载PDF
导出
摘要 目的测定儿童口服复方氯胺酮的血药浓度并探讨血药浓度与药效学的关系。方法用高效液相方法测定用药后不同时点氯胺酮(KET)、咪达唑仑(MZ)、阿托品(AT)的血药浓度;观察药物显效时间、镇静止痛效果。结果KET的tmax=(30±15)min,Cmax=(633±121)ng·mL-1;MZ的tmax=(30±15)min,Cmax=(105±35)ng·mL-1。患儿服药(10±4)min,血中可测到KET、MZ的含量;(30±20)min达峰;未检测到AT。结论复方氯胺酮口服液起效时间与其血药浓度高峰期相近。 Objective To monitor the blood concentration of ketamine(KET), midazolam(MZ) and atropine(AT) in children after the administration of compound ketamine oral solution(CKOS) and discuss the correlation-ship of concentration pharmacodynamics. Methods The blood concentration of KET (5 mg·kg -1), MZ (0.5 mg·kg -1) and AT (0.03 mg·kg -1) were monitored by high-performance liquid chromatograph. The trigger time of effect, the sedation effect, and the state of emotion were all studied. Results KET and MZ can be detected 10 min after the drug administration, and t max is about 30 min. AT hasn' t been detected all the time. The observation of pharmacodynamics: the trigger time was (13±4) min, the peak of sedation time was (33±20) min. Conclusion The sedative and ease pain effect of CKOS are correlated with the drug blood concentration.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2005年第1期50-53,共4页 The Chinese Journal of Clinical Pharmacology
基金 辽宁省自然科学基金资助项目(20022074)
关键词 氯胺酮口服液 咪达唑仑 高效液相色谱法 ketamine oral solution midazolam HPLC
  • 相关文献

参考文献7

二级参考文献20

共引文献25

同被引文献44

  • 1张锦,陈华,汪薇,王娟娟.复方氯胺酮口服液对大鼠海马CA1 CA3区NMDA受体1 GABA_A受体mRNA表达的影响[J].中国当代儿科杂志,2005,7(4):345-348. 被引量:1
  • 2王福民,刘娟.线性扫描极谱法测定盐酸氯胺酮[J].渭南师范学院学报,2006,21(2):55-57. 被引量:1
  • 3Jansen K, Darracot-Cankovic R. The nonmedical use of ketamine. J Psychoactive Drugs, 2001, 33:151-158.
  • 4Moore KA, Sklerov J, Levine B, et al. Urine concentrations of ketamine and norketamine following illegal consumption. J Anal Toxieol, 2001, 25 : 583-588.
  • 5Seay SS, Aucoin DP, Tyczkowska KL. Rapid high-performance liquid chromatographic method for determination of ketamine and its metabolite dehydronorketamine in equine serum. J Chromatogr, 1993, 620:281-287.
  • 6Ekins S, Wrightion SA. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab Rev, 1999, 31: 719-754.
  • 7Yanagihara Y, Kariya S, Ohtani M, et al. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes. Drug Metab Dispos, 2001, 29: 887-890.
  • 8Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos, 2002, 30: 853-858.
  • 9Geisslinger G, Menzel-Soglowe KS, Kamp HD, et al. Stereoselective high perfomanee liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma. J Chromatogr, 1991, 568: 165-176.
  • 10Feng N, Vollenweider FX, Minder El, et al. Development of a gas chromatography-mass spect ometry method for determination of ketamine in plasma and its application to human sampies. Ther Drug Monit, 1995,17:95-100.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部